All orders placed by 2pm EST will be shipped same day Free Shipping Over $150 Gift With Every Order All orders placed by 2pm EST will be shipped same day Free Shipping Over $150 Gift With Every Order

CJC-1295 (No DAC) 10MG

Categories:

CJC-1295 (No DAC) 10MG is a research-use-only peptide derived for experimental applications in a laboratory setting. This compound is intended for research purposes only, not for human or veterinary use. It is designed for academic and scientific investigation in controlled environments.

Price range: $55.00 through $80.00

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

CJC-1295 (No DAC) – 10 mg

CJC-1295 is a synthetic peptide analog of the endogenous growth hormone-releasing hormone (GHRH). Originally developed as a potential therapeutic agent in the 1980s, CJC-1295 has been widely utilized in preclinical and translational research to investigate its effects on growth hormone (GH) secretion, cell proliferation, and neuroprotection. The “No DAC” variant refers to the peptide lacking the diacetylated amino-terminal residues, which can impact its metabolic stability and bioactivity in certain experimental settings.

Research Context

CJC-1295 has been studied extensively for its ability to enhance GH secretion from pituitary somatotropes through activation of GHRH receptors. In vitro and in vivo research has explored its potential mechanisms, including modulation of the hypothalamic-pituitary axis, anti-apoptotic effects, and neuroprotective properties. The peptide has been utilized in both animal models and human trials (primarily as a drug delivery vector) to assess its impact on growth, aging, and metabolic processes. However, its use is limited to controlled research environments due to regulatory considerations and safety profiles.

Research Overview

CJC-1295 is typically administered via subcutaneous injection and has been characterized for its prolonged half-life compared to native GHRH. Preclinical studies have demonstrated that its administration can induce GH secretion without concurrent luteinizing hormone (LH) release, which differentiates it from other GHRH analogs. Research has also examined its role in modulating inflammation, cellular senescence, and tissue regeneration in aging models. Due to its stability, CJC-1295 remains a valuable tool for studying GH signaling pathways and potential therapeutic interventions.

Key Research Focus Areas

  • Growth hormone (GH) secretion modulation
  • Neuroprotection and aging research
  • Cell proliferation and tissue regeneration
  • Anti-inflammatory and anti-apoptotic effects
  • Pharmacokinetics and metabolic stability

Caution: This peptide is intended exclusively for use in research settings. Administration or distribution to individuals or entities outside of approved academic or institutional research protocols may violate applicable laws and regulations.

For research use only. Not for human or animal consumption.

Related Products

Age Verification!

*By continuing, you confirm eligibility and legal compliance.